Current biomarker-associated procedures of cancer modeling-a reference in the context of IDH1 mutant glioma.

Current biomarker-associated procedures of cancer modeling-a reference in the context of IDH1 mutant glioma.
复制标题

当前与IDH1突变胶质瘤背景下的癌症模型A参考的生物标志物相关程序。

DOI:
10.1038/s41419-020-03196-0
复制
发表时间:
2020-11-21
影响因子:
9
通讯作者:
Kahlert UD
Kahlert UD
中科院分区:
生物学1区
文献类型:
--
作者:
Mehrjardi NZ;Hänggi D;Kahlert UD

文献摘要

参考文献

被引文献

相似文献

异柠檬酸脱氢酶(IDH 1/2)是胶质母细胞瘤的中心分子标志物。提供具有突变IDH 1/2的体外或体内模型可以帮助准备设施以了解这些突变基因作为胶质瘤标记物的生物学,以及帮助改进治疗策略。在这篇综述中,我们首先总结了IDH及其突变的生物学原理,并概述了神经肿瘤临床背景下的核心初步发现。鉴于当前干细胞生物学和基因组编辑领域的广泛研究兴趣和令人兴奋的发展,本文的中心部分致力于介绍IDH突变(IDHMut)胶质瘤疾病建模策略的各种途径,并比较该领域的科学技术发现使用不同的工程方法。最后,通过给出我们对患者衍生和供体衍生疾病建模的益处和局限性的观点,我们的目标是提出在IDH 1和胶质瘤背景下需要回答的主要研究问题。
Isocitrate dehydrogenases (IDH1/2) are central molecular markers for glioblastoma. Providing in vitro or in vivo models with mutated IDH1/2 can help prepare facilities to understand the biology of these mutated genes as glioma markers, as well as help, improve therapeutic strategies. In this review, we first summarize the biology principles of IDH and its mutations and outline the core primary findings in the clinical context of neuro-oncology. Given the extensive research interest and exciting developments in current stem cell biology and genome editing, the central part of the manuscript is dedicated to introducing various routes of disease modeling strategies of IDH mutation (IDHMut) glioma and comparing the scientific-technological findings from the field using different engineering methods. Lastly, by giving our perspective on the benefits and limitations of patient-derived and donor-derived disease modeling respectively, we aim to propose leading research questions to be answered in the context of IDH1 and glioma.
DOI: 10.1007/s00401-009-0561-9
发表时间: 2009-10-01
影响因子: 12.7
作者:
Hartmann, Christian;Meyer, Jochen;von Deimling, Andreas
通讯作者: von Deimling, Andreas
DOI: 10.1038/s41592-018-0070-7
发表时间: 2018-08
期刊: Nature methods
影响因子: 48
作者:
Bian S;Repic M;Guo Z;Kavirayani A;Burkard T;Bagley JA;Krauditsch C;Knoblich JA
通讯作者: Knoblich JA
DOI: 10.1038/ncomms12700
发表时间: 2016-09-14
影响因子: 16.6
作者:
Carbonneau, Melissa;Gagne, Laurence M.;Lalonde, Marie-Eve;Germain, Marie-Anne;Motorina, Alena;Guiot, Marie-Christine;Secco, Blandine;Vincent, Emma E.;Tumber, Anthony;Hulea, Laura;Bergeman, Jonathan;Oppermann, Udo;Jones, Russell G.;Laplante, Mathieu;Topisirovic, Ivan;Petrecca, Kevin;Huot, Marc-Etienne;Mallette, Frederick A.
通讯作者: Mallette, Frederick A.
DOI: 10.1038/nature08617
发表时间: 2009-12-10
期刊: Nature
影响因子: 64.8
作者:
通讯作者: --
DOI: 10.1101/gad.294991.116
发表时间: 2017-04-15
影响因子: 10.5
作者:
Amankulor NM;Kim Y;Arora S;Kargl J;Szulzewsky F;Hanke M;Margineantu DH;Rao A;Bolouri H;Delrow J;Hockenbery D;Houghton AM;Holland EC
通讯作者: Holland EC